Algen Biotechnologies is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry, NAICS Code 54171.
Algen Biotechnologies Annual Revenue and Growth Rate
Note: Algen Biotechnologies's revenues are gauged from an analysis of company filings.
Algen Biotechnologies's Income Statement (based on Industry Averages)
Algen Biotechnologies P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Algen Biotechnologies is developing and marketing.
Algen Biotechnologies doesn't have any recent trademark applications, indicating Algen Biotechnologies is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
CRISPRINT research and development in the field of drug discovery; scientific research and product development in the field of genetics and drug discovery; scientific research, namely, identification, isolation, functional analysis, sequencing and mapping of genes; research and development in the field of biotechnology and gene networking technology for use in therapeutic discovery and development; scientific research and technological research in the fields of gene discovery, gene network informatics, and drug discovery; providing temporary use of nondownloadable medical software for managing therapeutic discovery activities related to gene networking, namely, screening and prioritizing therapeutic agents for further evaluation and development, discovering novel biomarkers, validating biomarker strategies, gathering insights for patient selection and stratification for therapeutic treatment, and generating and storing therapeutic insights about the role a particular gene plays in a given disease and about the mechanism of action and therapeutic index of particular therapeutic agents
08/09/2021
See all trademarks and details in the Full Report.
Market Share of Algen Biotechnologies's Largest Competitors
A competitive analysis shows these companies are in the same general field as Algen Biotechnologies, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Algen Biotechnologies.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Algen Biotechnologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.